Últimas Notícias
Poupe 55% 0
🐦 Os mais rápidos encontram as melhores ações. Poupe até 55% na InvestingPro na Black Friday
OBTER OFERTA
Fechar

Rydex Biotechnology Fund Class Investor (RYOIX)

Criar Alerta
Novo!
Criar Alerta
Website
  • Como notificação de alerta
  • Para utilizar esta função, inicie uma sessão na sua conta
Aplicação Móvel
  • Para utilizar esta função, inicie uma sessão na sua conta
  • Inicie uma sessão com o mesmo perfil de utilizador

Condição

Frequência

Uma vez
%

Frequência

Frequência

Método de Entrega

Estado

Adicionar/Remover de uma carteira Adicionar à watchlist
Adicionar a watchlist
Adicionar Posição

Posição adicionada com sucesso a:

Dê um nome à sua carteira de participações
 
77,34 +1,25    +1,64%
22/11 - Fechado. Moeda em USD
Tipo:  Fundo
Mercado:  E.U.A.
Emissor:  Rydex Funds
Classe de Ativo:  Açao
  • Classificação da Morningstar:
  • Ativos Totais: 79,06M
Rydex Biotechnology Inv 77,34 +1,25 +1,64%

Rydex Biotechnology Fund Class Investor - Vista Geral

 
Nesta página encontrará um perfil aprofundado de Rydex Biotechnology Fund Class Investor. Fique a saber mais sobre as pessoas-chave, o total de ativos, a estratégia de investimento e a informação de contacto de RYOIX, e mais.
Categoria

Health

Ativos Totais

79,06M

Despesas

1,39%

Data de Início

35886

Informações de Contacto

Endereço 9601 Blackwell Rd, Suite 500
Rockville,MD 20850
United States
Telefone 800.820.0888

Principais Executivos

Nome Título Desde Até
Adrian Bachman Portfolio Manager 2022 Agora
Biografia Mr. Bachman is a Director and Portfolio Manager of Guggenheim Investments and joined Guggenheim Investments in August of 2014. Before joining Guggenheim Investments, Mr. Bachman spent six years at Arrow Investment Advisors. As portfolio manager, Mr. Bachman managed the Arrow Dow Jones Global Yield ETF (GYLD) which provided multi asset class diversified income across five unique sources including high dividend paying global equities, real estate investment trusts, MLPs, sovereign debt and high yield corporate bonds. While at Arrow he also aided in the management of numerous other funds. Before joining Arrow Funds in June of 2008, Mr. Bachman spent eleven years at Rydex Investments in Rockville, Maryland. As portfolio manager, Mr. Bachman managed Rydex's Sector Rotation Fund and several sector funds. During the course of his tenure with Rydex, he also aided in the management of numerous other funds including Rydex's inverse, leveraged and international funds. Mr. Bachman has a bachelor's degree in finance and international business from the University of Maryland, College Park and has earned the Chartered Financial Analyst designation.
Brendan Cain Portfolio Manager 2022 Agora
Biografia Brendan Cain, CFA, Vice President and Portfolio Manager. Mr. Cain has been associated with the Adviser since 2006.
Spencer Crane Portfolio Manager 2022 Agora
Biografia Spencer Crane, CFA, Vice President and Portfolio Manager. Mr. Crane has been associated with the Adviser since 2012
Scott Miller Portfolio Manager 2022 Agora
Biografia Scott Miller, Vice President and Portfolio Manager. Mr. Miller has been associated with the Adviser since 2008.
Michael P. Byrum Vice President 1998 Agora
Biografia Michael P. Byrum, CFA, Senior Vice President—Mr. Byrum has been associated with the Security Investors since 1993. Mr. Byrum was the inaugural portfolio manager for many of the Rydex products, including the Rydex leveraged and inverse funds, sector fund lineup and alternative investment portfolios. Today, Mr. Byrum continues to play an instrumental role in product development and investment strategy at Guggenheim Investments and oversees the trading, research and portfolio management activities of the quantitative strategies team, which focuses on target beta, alternative and asset allocation strategies. He is the chairman of the Investment Strategy Committee and is a member of the Risk Management Committee and Credit Review Committee. Prior to joining the Security Investors, Mr. Byrum served in a brokerage capacity with Money Management Associates, the registered investment advisor to Rushmore Funds, Inc. He earned a B.S. in finance from the Miami University of Ohio. He also has earned the right to use the Chartered Financial Analyst® designation and is a member of the CFA Institute and the CFA Society of Washington.
Ryan A. Harder Graduate Trainee Risk Management 2008 2022
Biografia Ryan earned a BA in Economics, with honors, from Brock University in Ontario, Canada, and a M.Sc. in International Securities, Investment and Banking form the ICMA Centre, University of Reading, in the United Kingdom. He is a CFA Charterholder.
Michael J. Dellapa Director 2006 2015
Biografia Dellapa joined Rydex Investments in 2000 as a research analyst and was promoted to portfolio manager in 2003. In 2005, Dellapa became director of investment research and in 2007 became the director of Alternative Investment Strategies. Prior to joining Rydex Advisors, LLC, Mr. Dellapa worked as an equity analyst for Invista Capital and systems analyst for Accenture. He holds an engineering degree from the University of Maryland and MBA from the University of Chicago. Previously, he was owner/consultant of Dellapa Consulting Inc. as well as a senior consultant and an analyst at Andersen Consulting. Dellapa holds the Charted Financial Analyst designation.
Douglas T. Holmes Strategic Advisor 2008 2009
Biografia Doug is a Senior Principal of State Street Global Advisors and heads the Global Enhanced Equity Group. He specializes in portfolio construction, risk control, and implementation of enhanced equity portfolios. Doug is the co-inventor of SPDRs and continues to be involved in all related products discussed or created by the firm. Prior to joining State Street in 1984, Doug was a partner at Lovett, Ward & Bertelsen. Before this, he was affiliated with Batterymarch Financial Management and was a member of the New Product Committee of the American Stock Exchange. Doug has been working in the investment management industry since 1980. Doug has a BS in Mathematics from Northeastern University.
James R. King Director 2006 2008
Biografia James R. King, CFA, Portfolio Manager—Mr. King rejoined Security in 2011 as the lead portfolio manager for exchange-traded products. In the interval between 2008 and 2011, he served as special consultant to a pair of hedge funds ventures, one focused on long-short equity and the other on market neutral statistical arbitrage. Prior to that, he served at the Advisor in a variety of roles ranging from shareholder services representative to portfolio manager and director of trading. At the time of his departure in 2008, he was director of portfolio management, overseeing a suite of trader-friendly mutual funds. Mr. King holds a bachelor’s degree in finance from the University of Maryland, and has earned the Chartered Financial Analyst® designation. He has been quoted in several publications such as The Wall Street Journal, Reuters and BusinessWeek. He has also been a speaker at several industry events, discussing ETFs, trading strategies, index construction, and trader-friendly mutual funds.
Diretrizes para Comentários

Encorajamos o uso de comentários como forma de interagir com os nossos usuários, compartilhar a sua perspetiva e fazer perguntas. No entanto, a fim de manter o alto nível do discurso que todos nós valorizamos e esperamos, por favor, mantenha os seguintes critérios em mente:

  • Enriqueça a conversa
  • Mantenha-se focado no tema. Apenas coloque conteúdo relativo ao tópico.
  • Seja respeitoso. Até as opiniões negativas podem ser enquadradas de forma positiva e diplomática.
  • Use estilo de escrita padrão. Incluir pontuação e letras maiúsculas e minúsculas.
  • NOTA: Spam e/ou mensagens promocionais ou links dentro de um comentário serão removidos.
  • Evite palavrões, calúnias ou ataques pessoais dirigidos a um autor ou outro usuário.
  • Somente serão permitidos comentários em Português.

Os autores de spam ou abuso serão excluídos do site e proibidos de registro no futuro, a critério Investing.com.

RYOIX Fórum de Discussão

Escreva o que você pensa sobre Rydex Biotechnology Fund Class Investor
 
Tem certeza que deseja eliminar este gráfico?
 
Postar
Também publique em :
 
Substituir o gráfico anexado por um novo gráfico?
1000
A sua capacidade de comentar está suspensa devido a relatórios negativos por partes utilizadores. O estado será revisto pelos nossos moderadores.
Aguarde um minuto antes de tentar comentar novamente.
Obrigado pelo seu comentário. Por favor, note que todos os comentários estão automaticamente pendentes, em nosso sistema, até que aprovados por nossos moderadores. Por este motivo, pode demorar algum tempo antes que o mesmo apareça em nosso site.
 
Tem certeza que deseja eliminar este gráfico?
 
Postar
 
Substituir o gráfico anexado por um novo gráfico?
1000
A sua capacidade de comentar está suspensa devido a relatórios negativos por partes utilizadores. O estado será revisto pelos nossos moderadores.
Aguarde um minuto antes de tentar comentar novamente.
Anexar um gráfico a um comentário
Confirmar Bloqueio

Quer mesmo bloquear %USER_NAME%?

Se o fizer, não poderá consultar as mensagens de %USER_NAME% e vice versa em Investing.com.

Adicionou %USER_NAME% com sucesso à sua Lista de Bloqueios

Uma vez que acabou de desbloquear esta pessoa, deve aguardar 48 horas antes de bloqueá-la novamente.

Denunciar este comentário

Diga-nos o que achou deste comentário

Comentário denunciado

Obrigado!

Seu comentário foi enviado aos moderadores para revisão
Iniciar sessão com Apple
Registe-se com o Google
ou
Registe-se com email